Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.20)
# 3,642
Out of 5,182 analysts
58
Total ratings
40.54%
Success rate
-9.65%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $184 → $157 | $158.54 | -0.97% | 6 | Feb 10, 2026 | |
| PODD Insulet | Maintains: Overweight | $350 → $360 | $203.73 | +76.70% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $96.81 | +50.81% | 9 | Oct 16, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $16.20 | +23.46% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $20.61 | +297.87% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $131.58 | +88.48% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $469.21 | -27.75% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.62 | +141.66% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $1.47 | +1,736.73% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $94.78 | +17.11% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $63.98 | +124.68% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $124.79 | -55.12% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $70.93 | +4.33% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $80.99 | -5.33% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $12.83 | +601.48% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $95.25 | - | 1 | Dec 12, 2019 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Equal-Weight
Price Target: $184 → $157
Current: $158.54
Upside: -0.97%
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $203.73
Upside: +76.70%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $96.81
Upside: +50.81%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $16.20
Upside: +23.46%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $20.61
Upside: +297.87%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $131.58
Upside: +88.48%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $469.21
Upside: -27.75%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.62
Upside: +141.66%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $1.47
Upside: +1,736.73%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $94.78
Upside: +17.11%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $63.98
Upside: +124.68%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $124.79
Upside: -55.12%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $70.93
Upside: +4.33%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $80.99
Upside: -5.33%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $12.83
Upside: +601.48%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $95.25
Upside: -